The Makers of the Omnipod® Insulin Management System
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.omnipod.com.
The countries and languages where the Omnipod® System is available are listed below.
Please Select Your Country and Language
Media and Investor Inquiries
We would be happy to talk to you further. Please contact us via mail, phone, or email:
100 Nagog Park
Acton, MA 01720
Investor and corporate/financial media inquiries: [email protected]
U.S. product-related media inquiries: [email protected]
Media inquiries in Europe: [email protected]
Media inquiries in Canada: [email protected]
*Up to 72 hours of insulin delivery